The Market Reports

Index

1 Gabapentin Enacarbil Market Overview
1.1 Product Overview and Scope of Gabapentin Enacarbil
1.2 Gabapentin Enacarbil Segment by Type
1.2.1 Global Gabapentin Enacarbil Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Capsule
1.2.3 Tablet
1.3 Gabapentin Enacarbil Segment by Application
1.3.1 Gabapentin Enacarbil Sales Comparison by Application: (2021-2027)
1.3.2 Post-Herpetic Neuralgia (PHN)
1.3.3 Restless Legs Syndrome (RLS)
1.3.4 Others
1.4 Global Gabapentin Enacarbil Market Size Estimates and Forecasts
1.4.1 Global Gabapentin Enacarbil Revenue 2016-2027
1.4.2 Global Gabapentin Enacarbil Sales 2016-2027
1.4.3 Gabapentin Enacarbil Market Size by Region: 2016 Versus 2021 Versus 2027

2 Gabapentin Enacarbil Market Competition by Manufacturers
2.1 Global Gabapentin Enacarbil Sales Market Share by Manufacturers (2016-2021)
2.2 Global Gabapentin Enacarbil Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Gabapentin Enacarbil Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Gabapentin Enacarbil Manufacturing Sites, Area Served, Product Type
2.5 Gabapentin Enacarbil Market Competitive Situation and Trends
2.5.1 Gabapentin Enacarbil Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Gabapentin Enacarbil Players Market Share by Revenue
2.5.3 Global Gabapentin Enacarbil Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Gabapentin Enacarbil Retrospective Market Scenario by Region
3.1 Global Gabapentin Enacarbil Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Gabapentin Enacarbil Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Gabapentin Enacarbil Market Facts & Figures by Country
3.3.1 North America Gabapentin Enacarbil Sales by Country
3.3.2 North America Gabapentin Enacarbil Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Gabapentin Enacarbil Market Facts & Figures by Country
3.4.1 Europe Gabapentin Enacarbil Sales by Country
3.4.2 Europe Gabapentin Enacarbil Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Gabapentin Enacarbil Market Facts & Figures by Region
3.5.1 Asia Pacific Gabapentin Enacarbil Sales by Region
3.5.2 Asia Pacific Gabapentin Enacarbil Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Gabapentin Enacarbil Market Facts & Figures by Country
3.6.1 Latin America Gabapentin Enacarbil Sales by Country
3.6.2 Latin America Gabapentin Enacarbil Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Gabapentin Enacarbil Market Facts & Figures by Country
3.7.1 Middle East and Africa Gabapentin Enacarbil Sales by Country
3.7.2 Middle East and Africa Gabapentin Enacarbil Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Gabapentin Enacarbil Historic Market Analysis by Type
4.1 Global Gabapentin Enacarbil Sales Market Share by Type (2016-2021)
4.2 Global Gabapentin Enacarbil Revenue Market Share by Type (2016-2021)
4.3 Global Gabapentin Enacarbil Price by Type (2016-2021)

5 Global Gabapentin Enacarbil Historic Market Analysis by Application
5.1 Global Gabapentin Enacarbil Sales Market Share by Application (2016-2021)
5.2 Global Gabapentin Enacarbil Revenue Market Share by Application (2016-2021)
5.3 Global Gabapentin Enacarbil Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Arbor Pharma
6.1.1 Arbor Pharma Corporation Information
6.1.2 Arbor Pharma Description and Business Overview
6.1.3 Arbor Pharma Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Arbor Pharma Product Portfolio
6.1.5 Arbor Pharma Recent Developments/Updates
6.2 Astellas
6.2.1 Astellas Corporation Information
6.2.2 Astellas Description and Business Overview
6.2.3 Astellas Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Astellas Product Portfolio
6.2.5 Astellas Recent Developments/Updates
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Corporation Information
6.3.2 GlaxoSmithKline Description and Business Overview
6.3.3 GlaxoSmithKline Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
6.3.4 GlaxoSmithKline Product Portfolio
6.3.5 GlaxoSmithKline Recent Developments/Updates
6.4 Glenmark Pharma
6.4.1 Glenmark Pharma Corporation Information
6.4.2 Glenmark Pharma Description and Business Overview
6.4.3 Glenmark Pharma Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Glenmark Pharma Product Portfolio
6.4.5 Glenmark Pharma Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Pfizer Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Depomed
6.6.1 Depomed Corporation Information
6.6.2 Depomed Description and Business Overview
6.6.3 Depomed Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Depomed Product Portfolio
6.6.5 Depomed Recent Developments/Updates
6.7 Teva
6.6.1 Teva Corporation Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Teva Product Portfolio
6.7.5 Teva Recent Developments/Updates
6.8 Mylan
6.8.1 Mylan Corporation Information
6.8.2 Mylan Description and Business Overview
6.8.3 Mylan Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Mylan Product Portfolio
6.8.5 Mylan Recent Developments/Updates
6.9 Novartis
6.9.1 Novartis Corporation Information
6.9.2 Novartis Description and Business Overview
6.9.3 Novartis Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Novartis Product Portfolio
6.9.5 Novartis Recent Developments/Updates
6.10 Apotex
6.10.1 Apotex Corporation Information
6.10.2 Apotex Description and Business Overview
6.10.3 Apotex Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Apotex Product Portfolio
6.10.5 Apotex Recent Developments/Updates
6.11 Sun Pharmaceutical
6.11.1 Sun Pharmaceutical Corporation Information
6.11.2 Sun Pharmaceutical Gabapentin Enacarbil Description and Business Overview
6.11.3 Sun Pharmaceutical Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Sun Pharmaceutical Product Portfolio
6.11.5 Sun Pharmaceutical Recent Developments/Updates
6.12 Aurobindo Pharma
6.12.1 Aurobindo Pharma Corporation Information
6.12.2 Aurobindo Pharma Gabapentin Enacarbil Description and Business Overview
6.12.3 Aurobindo Pharma Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Aurobindo Pharma Product Portfolio
6.12.5 Aurobindo Pharma Recent Developments/Updates
6.13 Intas
6.13.1 Intas Corporation Information
6.13.2 Intas Gabapentin Enacarbil Description and Business Overview
6.13.3 Intas Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Intas Product Portfolio
6.13.5 Intas Recent Developments/Updates
6.14 Amneal
6.14.1 Amneal Corporation Information
6.14.2 Amneal Gabapentin Enacarbil Description and Business Overview
6.14.3 Amneal Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Amneal Product Portfolio
6.14.5 Amneal Recent Developments/Updates
6.15 Marksans Pharma
6.15.1 Marksans Pharma Corporation Information
6.15.2 Marksans Pharma Gabapentin Enacarbil Description and Business Overview
6.15.3 Marksans Pharma Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Marksans Pharma Product Portfolio
6.15.5 Marksans Pharma Recent Developments/Updates
6.16 Alkem
6.16.1 Alkem Corporation Information
6.16.2 Alkem Gabapentin Enacarbil Description and Business Overview
6.16.3 Alkem Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Alkem Product Portfolio
6.16.5 Alkem Recent Developments/Updates
6.17 Jiangsu Enhua
6.17.1 Jiangsu Enhua Corporation Information
6.17.2 Jiangsu Enhua Gabapentin Enacarbil Description and Business Overview
6.17.3 Jiangsu Enhua Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Jiangsu Enhua Product Portfolio
6.17.5 Jiangsu Enhua Recent Developments/Updates
6.18 Jiangsu Hengrui
6.18.1 Jiangsu Hengrui Corporation Information
6.18.2 Jiangsu Hengrui Gabapentin Enacarbil Description and Business Overview
6.18.3 Jiangsu Hengrui Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Jiangsu Hengrui Product Portfolio
6.18.5 Jiangsu Hengrui Recent Developments/Updates
6.19 Sailike Pharma
6.19.1 Sailike Pharma Corporation Information
6.19.2 Sailike Pharma Gabapentin Enacarbil Description and Business Overview
6.19.3 Sailike Pharma Gabapentin Enacarbil Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Sailike Pharma Product Portfolio
6.19.5 Sailike Pharma Recent Developments/Updates

7 Gabapentin Enacarbil Manufacturing Cost Analysis
7.1 Gabapentin Enacarbil Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Gabapentin Enacarbil
7.4 Gabapentin Enacarbil Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Gabapentin Enacarbil Distributors List
8.3 Gabapentin Enacarbil Customers

9 Gabapentin Enacarbil Market Dynamics
9.1 Gabapentin Enacarbil Industry Trends
9.2 Gabapentin Enacarbil Growth Drivers
9.3 Gabapentin Enacarbil Market Challenges
9.4 Gabapentin Enacarbil Market Restraints

10 Global Market Forecast
10.1 Gabapentin Enacarbil Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Gabapentin Enacarbil by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Gabapentin Enacarbil by Type (2022-2027)
10.2 Gabapentin Enacarbil Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Gabapentin Enacarbil by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Gabapentin Enacarbil by Application (2022-2027)
10.3 Gabapentin Enacarbil Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Gabapentin Enacarbil by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Gabapentin Enacarbil by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Gabapentin Enacarbil Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Gabapentin Enacarbil Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Gabapentin Enacarbil Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Gabapentin Enacarbil Covered in This Study
Table 5. Global Gabapentin Enacarbil Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Gabapentin Enacarbil Sales Share by Manufacturers (2016-2021)
Table 7. Global Gabapentin Enacarbil Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Gabapentin Enacarbil Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Gabapentin Enacarbil Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Gabapentin Enacarbil Manufacturing Sites and Area Served
Table 11. Manufacturers Gabapentin Enacarbil Product Type
Table 12. Global Gabapentin Enacarbil Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Gabapentin Enacarbil by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gabapentin Enacarbil as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Gabapentin Enacarbil Sales by Region (2016-2021) & (K Units)
Table 16. Global Gabapentin Enacarbil Sales Market Share by Region (2016-2021)
Table 17. Global Gabapentin Enacarbil Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Gabapentin Enacarbil Sales by Country (2016-2021) & (K Units)
Table 19. North America Gabapentin Enacarbil Sales Market Share by Country (2016-2021)
Table 20. North America Gabapentin Enacarbil Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Gabapentin Enacarbil Revenue Market Share by Country (2016-2021)
Table 22. Europe Gabapentin Enacarbil Sales by Country (2016-2021) & (K Units)
Table 23. Europe Gabapentin Enacarbil Sales Market Share by Country (2016-2021)
Table 24. Europe Gabapentin Enacarbil Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Gabapentin Enacarbil Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Gabapentin Enacarbil Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Gabapentin Enacarbil Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Gabapentin Enacarbil Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Gabapentin Enacarbil Revenue Market Share by Region (2016-2021)
Table 30. Latin America Gabapentin Enacarbil Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Gabapentin Enacarbil Sales Market Share by Country (2016-2021)
Table 32. Latin America Gabapentin Enacarbil Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Gabapentin Enacarbil Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Gabapentin Enacarbil Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Gabapentin Enacarbil Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Gabapentin Enacarbil Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Gabapentin Enacarbil Revenue Market Share by Country (2016-2021)
Table 38. Global Gabapentin Enacarbil Sales (K Units) by Type (2016-2021)
Table 39. Global Gabapentin Enacarbil Sales Market Share by Type (2016-2021)
Table 40. Global Gabapentin Enacarbil Revenue (Million US$) by Type (2016-2021)
Table 41. Global Gabapentin Enacarbil Revenue Share by Type (2016-2021)
Table 42. Global Gabapentin Enacarbil Price (US$/Unit) by Type (2016-2021)
Table 43. Global Gabapentin Enacarbil Sales (K Units) by Application (2016-2021)
Table 44. Global Gabapentin Enacarbil Sales Market Share by Application (2016-2021)
Table 45. Global Gabapentin Enacarbil Revenue (Million US$) by Application (2016-2021)
Table 46. Global Gabapentin Enacarbil Revenue Share by Application (2016-2021)
Table 47. Global Gabapentin Enacarbil Price (US$/Unit) by Application (2016-2021)
Table 48. Arbor Pharma Corporation Information
Table 49. Arbor Pharma Description and Business Overview
Table 50. Arbor Pharma Gabapentin Enacarbil Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Arbor Pharma Gabapentin Enacarbil Product
Table 52. Arbor Pharma Recent Developments/Updates
Table 53. Astellas Corporation Information
Table 54. Astellas Description and Business Overview
Table 55. Astellas Gabapentin Enacarbil Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Astellas Gabapentin Enacarbil Product
Table 57. Astellas Recent Developments/Updates
Table 58. GlaxoSmithKline Corporation Information
Table 59. GlaxoSmithKline Description and Business Overview
Table 60. GlaxoSmithKline Gabapentin Enacarbil Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. GlaxoSmithKline Gabapentin Enacarbil Product
Table 62. GlaxoSmithKline Recent Developments/Updates
Table 63. Glenmark Pharma Corporation Information
Table 64. Glenmark Pharma Description and Business Overview
Table 65. Glenmark Pharma Gabapentin Enacarbil Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Glenmark Pharma Gabapentin Enacarbil Product
Table 67. Glenmark Pharma Recent Developments/Updates
Table 68. Pfizer Corporation Information
Table 69. Pfizer Description and Business Overview
Table 70. Pfizer Gabapentin Enacarbil Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Pfizer Gabapentin Enacarbil Product
Table 72. Pfizer Recent Developments/Updates
Table 73. Depomed Corporation Information
Table 74. Depomed Description and Business Overview
Table 75. Depomed Gabapentin Enacarbil Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Depomed Gabapentin Enacarbil Product
Table 77. Depomed Recent Developments/Updates
Table 78. Teva Corporation Information
Table 79. Teva Description and Business Overview
Table 80. Teva Gabapentin Enacarbil Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Teva Gabapentin Enacarbil Product
Table 82. Teva Recent Developments/Updates
Table 83. Mylan Corporation Information
Table 84. Mylan Description and Business Overview
Table 85. Mylan Gabapentin Enacarbil Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Mylan Gabapentin Enacarbil Product
Table 87. Mylan Recent Developments/Updates
Table 88. Novartis Corporation Information
Table 89. Novartis Description and Business Overview
Table 90. Novartis Gabapentin Enacarbil Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Novartis Gabapentin Enacarbil Product
Table 92. Novartis Recent Developments/Updates
Table 93. Apotex Corporation Information
Table 94. Apotex Description and Business Overview
Table 95. Apotex Gabapentin Enacarbil Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Apotex Gabapentin Enacarbil Product
Table 97. Apotex Recent Developments/Updates
Table 98. Sun Pharmaceutical Corporation Information
Table 99. Sun Pharmaceutical Description and Business Overview
Table 100. Sun Pharmaceutical Gabapentin Enacarbil Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Sun Pharmaceutical Gabapentin Enacarbil Product
Table 102. Sun Pharmaceutical Recent Developments/Updates
Table 103. Aurobindo Pharma Corporation Information
Table 104. Aurobindo Pharma Description and Business Overview
Table 105. Aurobindo Pharma Gabapentin Enacarbil Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Aurobindo Pharma Gabapentin Enacarbil Product
Table 107. Aurobindo Pharma Recent Developments/Updates
Table 108. Intas Corporation Information
Table 109. Intas Description and Business Overview
Table 110. Intas Gabapentin Enacarbil Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Intas Gabapentin Enacarbil Product
Table 112. Intas Recent Developments/Updates
Table 113. Amneal Corporation Information
Table 114. Amneal Description and Business Overview
Table 115. Amneal Gabapentin Enacarbil Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Amneal Gabapentin Enacarbil Product
Table 117. Amneal Recent Developments/Updates
Table 118. Marksans Pharma Corporation Information
Table 119. Marksans Pharma Description and Business Overview
Table 120. Marksans Pharma Gabapentin Enacarbil Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Marksans Pharma Gabapentin Enacarbil Product
Table 122. Marksans Pharma Recent Developments/Updates
Table 123. Alkem Corporation Information
Table 124. Alkem Description and Business Overview
Table 125. Alkem Gabapentin Enacarbil Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. Alkem Gabapentin Enacarbil Product
Table 127. Alkem Recent Developments/Updates
Table 128. Jiangsu Enhua Corporation Information
Table 129. Jiangsu Enhua Description and Business Overview
Table 130. Jiangsu Enhua Gabapentin Enacarbil Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 131. Jiangsu Enhua Gabapentin Enacarbil Product
Table 132. Jiangsu Enhua Recent Developments/Updates
Table 133. Jiangsu Hengrui Corporation Information
Table 134. Jiangsu Hengrui Description and Business Overview
Table 135. Jiangsu Hengrui Gabapentin Enacarbil Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 136. Jiangsu Hengrui Gabapentin Enacarbil Product
Table 137. Jiangsu Hengrui Recent Developments/Updates
Table 138. Sailike Pharma Corporation Information
Table 139. Sailike Pharma Description and Business Overview
Table 140. Sailike Pharma Gabapentin Enacarbil Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 141. Sailike Pharma Gabapentin Enacarbil Product
Table 142. Sailike Pharma Recent Developments/Updates
Table 143. Production Base and Market Concentration Rate of Raw Material
Table 144. Key Suppliers of Raw Materials
Table 145. Gabapentin Enacarbil Distributors List
Table 146. Gabapentin Enacarbil Customers List
Table 147. Gabapentin Enacarbil Market Trends
Table 148. Gabapentin Enacarbil Growth Drivers
Table 149. Gabapentin Enacarbil Market Restraints
Table 150. Global Gabapentin Enacarbil Sales Forecast by Type (2022-2027) & (K Units)
Table 151. Global Gabapentin Enacarbil Sales Market Share Forecast by Type (2022-2027)
Table 152. Global Gabapentin Enacarbil Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 153. Global Gabapentin Enacarbil Revenue Market Share Forecast by Type (2022-2027)
Table 154. Global Gabapentin Enacarbil Sales Forecast by Application (2022-2027) & (K Units)
Table 155. Global Gabapentin Enacarbil Sales Market Share Forecast by Application (2022-2027)
Table 156. Global Gabapentin Enacarbil Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 157. Global Gabapentin Enacarbil Revenue Market Share Forecast by Application (2022-2027)
Table 158. Global Gabapentin Enacarbil Sales Forecast by Region (2022-2027) & (K Units)
Table 159. Global Gabapentin Enacarbil Sales Market Share Forecast by Region (2022-2027)
Table 160. Global Gabapentin Enacarbil Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 161. Global Gabapentin Enacarbil Revenue Market Share Forecast by Region (2022-2027)
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Gabapentin Enacarbil
Figure 2. Global Gabapentin Enacarbil Market Share by Type in 2020 & 2027
Figure 3. Capsule Product Picture
Figure 4. Tablet Product Picture
Figure 5. Global Gabapentin Enacarbil Market Share by Application in 2020 & 2027
Figure 6. Post-Herpetic Neuralgia (PHN)
Figure 7. Restless Legs Syndrome (RLS)
Figure 8. Others
Figure 9. Global Gabapentin Enacarbil Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Gabapentin Enacarbil Market Size 2016-2027 (US$ Million)
Figure 11. Global Gabapentin Enacarbil Sales 2016-2027 (K Units)
Figure 12. Global Gabapentin Enacarbil Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Gabapentin Enacarbil Sales Share by Manufacturers in 2020
Figure 14. Global Gabapentin Enacarbil Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Gabapentin Enacarbil Players: Market Share by Revenue in 2020
Figure 16. Gabapentin Enacarbil Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Gabapentin Enacarbil Sales Market Share by Region (2016-2021)
Figure 18. Global Gabapentin Enacarbil Sales Market Share by Region in 2020
Figure 19. Global Gabapentin Enacarbil Revenue Market Share by Region (2016-2021)
Figure 20. Global Gabapentin Enacarbil Revenue Market Share by Region in 2020
Figure 21. U.S. Gabapentin Enacarbil Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Gabapentin Enacarbil Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Gabapentin Enacarbil Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Gabapentin Enacarbil Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Gabapentin Enacarbil Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Gabapentin Enacarbil Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Gabapentin Enacarbil Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Gabapentin Enacarbil Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Gabapentin Enacarbil Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Gabapentin Enacarbil Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Gabapentin Enacarbil Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Gabapentin Enacarbil Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Gabapentin Enacarbil Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Gabapentin Enacarbil Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Gabapentin Enacarbil Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Gabapentin Enacarbil Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Gabapentin Enacarbil Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Gabapentin Enacarbil Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Gabapentin Enacarbil Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Gabapentin Enacarbil Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Gabapentin Enacarbil Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Gabapentin Enacarbil Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Gabapentin Enacarbil Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Gabapentin Enacarbil Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Gabapentin Enacarbil by Type (2016-2021)
Figure 46. Sales Market Share of Gabapentin Enacarbil by Application (2016-2021)
Figure 47. Sales Market Share of Gabapentin Enacarbil by Application in 2020
Figure 48. Revenue Share of Gabapentin Enacarbil by Application (2016-2021)
Figure 49. Revenue Share of Gabapentin Enacarbil by Application in 2020
Figure 50. Manufacturing Cost Structure of Gabapentin Enacarbil
Figure 51. Manufacturing Process Analysis of Gabapentin Enacarbil
Figure 52. Gabapentin Enacarbil Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed